Advertisement

Head & Neck Cancer | Tumor

CURE’s head & neck cancer page is a go-to resource for oncology news and updates in the world of head & neck cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight to the latest treatments and research in head & neck cancer.

Shannen Doherty’s Cancer Metastasized, Nonprofit Established in Memory of Technoblade and More

June 9th 2023

From Shannen Doherty’s announcement that her breast cancer spread to her brain to a nonprofit being established in memory of the late YouTuber, Technoblade, here’s what’s happening in the oncology space this week.

Edward James Olmos, Khloé Kardashian Discuss Cancer, Survivor Makes a Musical About Her Diagnosis and More

June 2nd 2023

From Edward James Olmos and Khloé Karsashian both discussing their cancer diagnoses to a survivor making a movie musical about her diagnosis and more, here’s what’s happening in the oncology space this week.

Hank Green Diagnosed With Lymphoma, Jeff Bridges and Martina Navratilova Provide Cancer Updates and More

May 26th 2023

From YouTuber Hank Green announcing his lymphoma diagnosis, to Jeff Bridges, Martina Navratilova and Leanne Hainsby giving updates on their cancer, here’s what’s happening in the oncology space this week.

Social Supports Help Women With Head and Neck Cancer Face Disease, Treatments

May 9th 2023

A small survey of women with head and neck cancer found that while many experience physical and emotional distress, social supports can help.

Caregiver Provides ‘Pillar of Sense’ to Patient During Cancer Treatment

April 21st 2023

A patient with head and neck cancer highlights the importance of a strong support system throughout the time he was recovering from surgery.

HPV Causes Multiple Cancers, Though Knowledge on the Connection Is Lagging

April 18th 2023

HPV vaccination rates and public knowledge about the connection between the virus and certain cancer types are below what they should be, research found.

First Patient Dosed in Phase 1/2 Trial Assessing Novel Immunotherapy Alone, With Keytruda

April 12th 2023

Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.

My Journey with Oral Cancer

April 10th 2023

I had what I thought was a canker sore that didn't heal. It ended up being cancer.

‘Jurassic Park’ Star Announced Lymphoma Diagnosis, Martina Navratilova Is Cancer-Free and More

March 24th 2023

From Sam Neill announcing his cancer diagnosis to Martina Navratilova stating that she is now cancer-free, here’s what’s happening in the oncology space this week.

Patients With Head and Neck Cancer Require Double-Testing for Accurate Prognosis

March 13th 2023

A recent study finds patients who test positive for an HPV biomarker may not be positive for HPV itself, and these patients see significantly lower five-year survival rates.

'Ugly Blessings’ and Blooming From Cancer’s Lessons

March 8th 2023

After being diagnosed with a rare cancer, I met some amazing people and have a new appreciation for life.

The Invisible Side Effect of Visible Cancer Survivorship

March 6th 2023

How do survivors of head and neck cancer cope with drastic changes to one of the most visibly identifiable body parts — the head?

Dealing With Life-Changing Cancer My Own Way

March 5th 2023

When I sit down with my paint brush, despite my cancer history, I don’t feel different anymore.

Oral Mucositis Drug Is Under Review by the FDA

February 15th 2023

The Food and Drug Administration agreed to speed up the review of avasopasem to treat severe oral mucositis in patients with head and neck cancer.

Smoking Cessation May Boost Survival in Patients with Head and Neck Cancer

February 9th 2023

Patients who are looking to quit smoking to better their survival and health outcomes should talk to their health care team about different methods to do so, an expert said.

Low-Dose Immunotherapy Boosts Survival in Head and Neck Cancer

January 25th 2023

Opdivo — even when given in a low dose — was shown to improve outcomes in patients with advanced head and neck squamous cell carcinoma, highlighting a new option for patients who cannot receive the full dose.

Martina Navratilova Receives Cancer Diagnoses, Jill Biden to Have a Skin Lesion Removed and More

January 6th 2023

From tennis star Martina Navratilova’s two cancer diagnoses to First Lady Jill Biden undergoing Mohs surgery to have a suspicious lesion removed and musician deaths, here’s what’s happening in the cancer space this week.

Three-Drug Regimen Boosts Outcomes in HPV-Related Cancers

January 4th 2023

A novel three-drug combination bested standard-of-care regimens for patients with human papillomavirus-related cancers, according to phase 2 study results.

‘Duran Duran’ Guitarist Misses Hall of Fame Induction Due to Cancer, ‘Yellowstone’ Actor Discusses His Diagnosis and More

November 11th 2022

From the singer of “Duran Duran” revealing his stage 4 cancer diagnosis — and missing the band’s induction to the Rock & Roll Hall of Fame because of it — to Barry Corbin’s oral cancer fears, here’s what’s happening in the oncology space this week.

Trial to Investigate if a Novel Drug Can Foster Keytruda Effectiveness in Solid Cancers

October 11th 2022

NC410 plus Keytruda will be studied in a phase 1b/2 trial for patients with certain solid cancers that either did not respond to or have not been treated with an immunotherapy agent.

FDA Fast Tracks Investigational Drug With or Without Keytruda for Possible Approval for Head and Neck Cancer

October 10th 2022

The FDA granted a fast track designation to an investigational drug alone and in combination with Keytruda to treat patients with HPV recurrent/metastatic head and neck squamous cell carcinoma.

Active Surveillance ‘Most Definitely’ a Viable Treatment Option for Some Patients with Thyroid Cancer, Says Expert

September 29th 2022

Compared with surgery, active surveillance was just as effective and lowered anxiety levels in patients with low-risk papillary thyroid cancer.

Early-Phase Trial to Study Novel Drug, With or Without Keytruda, in Solid Cancers

September 27th 2022

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

A Shift in Focus for Head and Neck Cancer Treatment

September 20th 2022

Years ago, the goal of head and neck cancer treatment was strictly focused on a cure. Now, there has been a slight change in approach to improve survival rates while preserving quality of life.

Keytruda Treatment Regimen Misses Survival Goal in Head and Neck Cancer

July 20th 2022

The addition of Keytruda to chemoradiation, followed by maintenance Keytruda, did not lead to a statistically significant event-free survival benefit in patients with locally advanced head and neck squamous cell carcinoma.

Trial Launched to Analyze Safety of Novel Drug to Treat Severe Side Effect that Occurs in Approximately Half of Patients With Advanced Cancer

July 15th 2022

The first patient enrolled onto a phase 1 trial has received TCMB07, an investigational drug, for the treatment of cachexia, a severe disorder that may occur in more than half of patients with advanced-stage cancer.

Study of Novel Drug Combo in Head and Neck Cancer Closed After Several Patient Deaths

July 12th 2022

A clinical trial reviewing the safety and efficacy of a treatment regimen of enoblituzumab in combination with either retifanlimab or tebotelimab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck has been stopped by the manufacturer of the cancer drugs.

5 FDA Cancer Drug Approvals for Solid Tumors That Patients May Have Missed

June 29th 2022

Here is a roundup of cancer treatments that were approved by the FDA in the spring of 2022 that patients may have missed.

I'm a Cancer Survivor... What Now?

June 15th 2022

Although much has changed in the past two decades, more needs to be done to prepare cancer survivors for what happens after their treatments end.

New Drug May Mitigate Incidence, Severity of Chemotherapy-Related Oral Mucositis in Patients With Head and Neck Cancer

June 4th 2022

Avasopasem manganese is the first drug that has been shown to reduce the incidence and severity of chemotherapy-related oral mucositis in patients with head and neck cancer, research showed.

NEXT PAGE
PREVIOUS PAGE
Advertisement
Advertisement